Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), University of Montreal - Faculté de Pharmacie, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Université de Montréal - Faculty of Pharmacy, University Health Network - Princess Margaret Bioinformatics and Computational Genomics Laboratory, University Health Network - Princess Margaret Bioinformatics and Computational Genomics Laboratory, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO)Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO) and Vall d’Hebron Institute of Oncology (VHIO)

SOLTI Breast Cancer Research Group, SOLTI Breast Cancer Research Group, SOLTI Breast Cancer Research Group, Hospital Clínico de Valencia, Vall d'Hebron Institute of Oncology, Vall d’Hebron Institute of Oncology (VHIO), Universitat Politécnica de Catalunya, Hospital Clinic of Barcelona - Department of Medical Oncology, Hospitalet de Llobregat - Department of Medical Oncology, Hospital Universitario IIS-Fundación Jiménez Díaz (IIS-FJD, UAM)/CIBERER, Hospital Universitari Son Espases, University of Deusto, University of Seville - Hospital Universitario Virgen del Rocío, SOLTI Breast Cancer Research Group, Hospital San Pedro de Alcántara, SOLTI Breast Cancer Research Group, SOLTI Breast Cancer Research Group, Hospital Clinic of Barcelona - Department of Medical Oncology and SOLTI Breast Cancer Research Group

Vall d’Hebron Institute of Oncology (VHIO), affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Vall d’Hebron Institute of Oncology (VHIO), affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO)Hospital Vall d’Hebron, Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO) and Vall d’Hebron Institute of Oncology (VHIO)

Istituto Oncologico Veneto – IRCCS, SOLTI Breast Cancer Research Group, European Institute of Oncology (IEO) IRCCS - Division of New Drugs and Early Drug Development for Innovative Therapies, IRCCS-Fondazione Bietti, University of Genova - Department of Internal Medicine and Medical Specialties (DiMI), University of Piemonte Orientale, Universidad Católica de Salta, - Hospital General Universitario Gregorio Marañón, IRCCS Ospedale Policlinico San Martino, Hospital Clinic of Barcelona - Department of Medical Oncology, Università degli Studi di Udine and Vall d’Hebron Institute of Oncology (VHIO)